Conflict of interest
Henrik Horndalsveen: Advisory board: Janssen. Honoraria: AstraZeneca, Pfizer, Roche. Bjørn Henning Grønberg: Advisory board: AstraZeneca, BMS, Debiopharm, Eli Lilly, Janssen, MSD, Novartis, Pfizer, Roche, Takeda. Honoraria: AstraZeneca, Bayer, BMS, Bohringer Ingelheim, Debiopharm, Eli Lilly, MSD, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi, Takeda. Research funding: AstraZeneca, Roche. Spouse: Employee and shareholder of Eli Lilly and Company. Tarje Onsøien Halvorsen: Honoraria: AstraZeneca, MSD, Pierre Fabre, Pfizer. Travel support: AstraZeneca, MSD. Vilde Drageset Haakensen: Advisory boards: Novartis, Astra Zeneca, Pfizer. Honoraria: BMS, Astra Zeneca, Takeda. Åslaug Helland: Financial support and/or study drug from AstraZeneca, Roche, Novartis, Incyte, Eli Lilly, Ultimovacs and BMS, in association with clinical studies. Adv board: AstraZeneca, BMS, Janssen, MSD, Pfizer, Roche, Takeda, Sanofi, Bayer, Abbvie. The remaining authors declare that they have no competing interests.